Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39393406 add-on in remitted unipolar or bipolar depression
2015-002106-36Phase 2Suspended
- Sponsor
- CliniRx
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) and Bipolar Depression (BDep) comparing JNJ-39393406 add-on with Placebo add-on (2 arms). Primary endpoints: Composite BACS score and MADRS score. Started Oct 2015; status: suspended.
02
Drugs
JNJ-39393406
03
Conditions
major depressive disorder (MDD)Bipolar Depression (BDep)
Beyond the preview
Go deeper on 2015-002106-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002106-36.